Thank you, will respond to your submission as soon as possible.
Opened late last year by Prime Minister Gillard, The Kinghorn Cancer Centre is a joint venture between the Garvan Institute of Medical Research and St Vincent’s Hospital.
Associate Professor Phillip Stricker was appointed Clinical Director Prostate Cancer Research at The Kinghorn Cancer Centre. In response to the $5.5 million dollars funding over four years, he said, “The two organisations have already built a strong international reputation for the quality of their combined prostate cancer research, and this funding will further bolster that. Over many years, the Garvan and St Vincents Prostate Cancer Centre has pioneered new diagnostic techniques, introduced new biomarkers for early and advanced prostate cancer, and introduced the study of quality of life outcomes. Genomic research is a strong and welcome addition to an already-potent arsenal of tools.”
Reporter Sophie Scott's story, New pain-free treatment for prostate cancer, investigates the new and relatively painless treatment referred to generally as focal therapy. Dr Sricker, who is trialling focal therapies at St Vincent's Hospital, gives an insight into the Nanoknife treatment.
Key aspects
From diagnosis and treatment to rehabilitation and research, I believe my highly experienced team and I bring a multifaceted approach to understanding and helping our patients. A summary of these key aspects of that approach is available here in PDF format. If you are suffering from prostate cancer or have reason to believe you might be, you are welcome to contact us or, intially, complete our comprehensive second opinion form.
